Transpulmonary Thermodilution Measurements in Patients With Heart Diseases

NCT02035007 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-06-26

No results posted yet for this study

Summary

The purpose of this study is to examine the validation of the PiCCO (Pulse Contour Cardiac Output)-derived transpulmonary thermodilution technology in patients with heart diseases.

Conditions

  • Heart Diseases

Interventions

DEVICE

PiCCO Catheter (Pulsiocath 5F)

Measuring of PiCCO derived values

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Marco Maggiorini, Prof MD · University Hospital Zurich, Medical Intensive Care Unit

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035007 on ClinicalTrials.gov